Chemist’s Nanomaterial Breakthroughs Offer New Hope for Early Cancer Detection and Drug Standardization
A novel suite of research focused on nanomaterials is poised to revolutionize cancer diagnostics and pharmaceutical quality control, spearheaded by the work of Leonese chemist Guillermo Redondo Fernández. His doctoral thesis, recently recognized wiht the San Alberto Magno prize, details advancements with the potential to detect breast cancer earlier and ensure the safety and efficacy of next-generation nanodrugs.
Early Detection of Breast Cancer Thru Novel PSA Sensor
Traditionally associated with prostate cancer, Prostate Specific Antigen (PSA) is increasingly recognized as a potential biomarker for a specific type of breast cancer, even when present in minimal quantities. Fernández’s research has yielded a sensor capable of detecting this protein in women, offering a potential pathway for earlier diagnosis than current radiological methods like mammography allow.”This tool, if developed, would be useful for early detection of a type of breast cancer when it is not yet visible,” a leading researcher explained.
Biocompatible Nanomaterials Enhance Diagnostic Imaging
Beyond cancer detection, Fernández’s work extends to improving diagnostic imaging itself. He developed a carbon-based nanomaterial, designed to be biocompatible, that functions as a contrast agent in diagnostic tests. This innovation promises to increase resolution in tests like magnetic resonance imaging (MRI), mirroring the functionality of hafnium while potentially offering improved safety profiles.
Identifying Cells with Carbon-Based Analytical Methodology
A third key component of Fernández’s thesis focuses on accurately identifying human cells, a challenge frequently enough complicated by the presence of artifacts that can mimic cellular structures. His team developed an analytical methodology utilizing carbon materials to definitively identify cells by “feeding them these biocompatible nanomaterials and we know that they are cells,” as explained by Fernández.
From Biology to Chemistry: A Fusion of Passions
Fernández’s journey reflects a deep-rooted interest in both biology and chemistry. he ultimately chose to pursue chemistry,but his research has allowed him to integrate both disciplines. “It is the fusion of my two passions,” he said with satisfaction. he recognizes the often-invisible impact of basic research, stating, “I do not produce medicines, I do not sell them, but I am in the middle and it is a pride to know that from here you can fight cancer and extend life expectancy. I am passionate about improving people’s lives.”
Hopes for Commercialization and Continued Investment in Spanish Science
Fernández expressed a strong desire to see his PSA sensor brought to market. “I would like some company to be interested in producing the PSA sensor. A type of breast cancer would be detected early,” he noted. He also highlighted the need for increased investment in scientific research in Spain, observing that “Since the covid happened we have returned to the pre-covid situation, a little more investment in science in Spain would be needed. The ability to produce science is incredible. If there is money and interest there is progress. They are not miracles or magic.”
A Thriving Biopharmaceutical Sector in León
Despite his current work in the UK, Fernández remains connected to his roots, acknowledging the growing biopharmaceutical sector in León, Spain. “Many of my career colleagues work here.I think it will have a future. Maybe one day I can bring back things I’ve learned from,” he said. He also expressed optimism about the ongoing improvements to the city of León, hoping the city’s walls will one day be made walkable, similar to those in Lugo.
While content in his current role, Fernández admits to missing Spain and León, but remains open to the possibility of returning in the future. The San Alberto Magno award, sponsored by Isolina Cueli in memory of josé Luis GarcÃa Vallina, holds particular significance for him. “Being recognized for your work at home doesn’t happen every day. it was difficult for me to fall asleep,” he confessed.
